We are live on
!
Find out more
DCM
Decatur Capital Management Portfolio holdings
AUM
$219M
1-Year Est. Return
36.12%
This Fund
S&P 500
This Quarter
Est. Return
+4.31%
1 Year Est. Return
+36.12%
3 Year Est. Return
+131.91%
5 Year Est. Return
+185.8%
10 Year Est. Return
+862.87%
AUM
$217M
AUM Growth
+$10.9M
(+5.3%)
Cap. Flow
+$3.83M
Cap. Flow
% of AUM
1.76%
Top 10 Holdings %
Top 10 Hldgs %
61.8%
Holding
51
New
3
Increased
39
Reduced
4
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coca-Cola
KO
|
+$3.24M |
| 2 |
Microsoft
MSFT
|
+$3.08M |
| 3 |
CubeSmart
CUBE
|
+$2.51M |
| 4 |
SAP
SAP
|
+$204K |
| 5 |
CRH
CRH
|
+$193K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$2.02M |
| 2 |
UnitedHealth
UNH
|
+$1.89M |
| 3 |
Cadence Design Systems
CDNS
|
+$1.41M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$239K |
| 5 |
Broadcom
AVGO
|
+$44.7K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 51.51% |
| 2 | Communication Services | 13.2% |
| 3 | Consumer Discretionary | 10.41% |
| 4 | Healthcare | 9.09% |
| 5 | Financials | 4.69% |
Similar funds
WA
FCM
UAM
SIAG
ORP
LA
BFA
MWM
Decatur Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Decatur Capital Management held 51 positions worth $217M, up 5.3% from $206M the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Decatur Capital Management's Q3 2024 filing shows 3 new, 39 increased, 4 reduced and 1 closed positions. Its largest new stake was Coca-Cola: 47,247 shares worth $3.4M. The largest sale was Vertex Pharmaceuticals, an estimated $2.02M.
By sector, the portfolio is most concentrated in Technology at 52% of assets, down from 52% a quarter earlier, followed by Communication Services and Consumer Discretionary.
- Decatur Capital Management's largest Q3 2024 buy was Coca-Cola: 47,247 shares worth $3.4M.
- Decatur Capital Management added most to Microsoft in Q3 2024, an estimated $3.08M increase.
- Decatur Capital Management's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $2.02M.
- Decatur Capital Management fully exited Novo Nordisk in Q3 2024, selling an estimated $239K.
- Decatur Capital Management's ten largest holdings make up 62% of its $217M portfolio in Q3 2024.
- Decatur Capital Management opened 3 new positions and closed 1 in Q3 2024.
- Decatur Capital Management's portfolio value rose 5.3% quarter-over-quarter to $217M.
Based on Decatur Capital Management's 13F filing for Q3 2024, filed 26 Nov 2024.